desipramine has been researched along with fingolimod hydrochloride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dawson, G; Qin, J | 1 |
1 other study(ies) available for desipramine and fingolimod hydrochloride
Article | Year |
---|---|
Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants.
Topics: Animals; Antidepressive Agents, Tricyclic; Cathepsins; Cell Line, Tumor; Cells, Cultured; Cysteine Proteinase Inhibitors; Desipramine; Enzyme Inhibitors; Fibroblasts; Fingolimod Hydrochloride; Humans; Hydrolases; Immunosuppressive Agents; Leupeptins; Mice; Neurons; Propylene Glycols; Sphingomyelin Phosphodiesterase; Sphingosine | 2011 |